申请人:ABBOTT LABORATORIES
公开号:EP0405506A1
公开(公告)日:1991-01-02
A tetrapeptide type-B CCK receptor ligand of the formula
A-B-C-D
or a pharmaceutically acceptable salt thereof, which is useful for treating central nervous system disorders, substance abuse, gastrointestinal disorders, endocrine disorders, eating-related disorders and treatment of shock, respiratory and cardiocirculatory insufficiencies.
式中的四肽-B 型 CCK 受体配体
A-B-C-D
或其药学上可接受的盐,可用于治疗中枢神经系统疾病、药物滥用、胃肠功能紊乱、内分泌失调、进食相关疾病以及休克、呼吸和心血管功能不全的治疗。